Dag Heldal
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 12
- Platelet Disorders and Treatments 3
- Acute Myeloid Leukemia Research 2
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- T-cell and B-cell Immunology 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Acute Lymphoblastic Leukemia research 2
Dag Heldal
17 papers receiving 409 citations
Peers
Comparison fields: 5 of 47
- Hematology 287
- Genetics 161
- Transplantation 23
- Immunology 179
- Oncology 89
Countries citing papers authored by Dag Heldal
This map shows the geographic impact of Dag Heldal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Heldal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Heldal more than expected).
Fields of papers citing papers by Dag Heldal
This network shows the impact of papers produced by Dag Heldal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Heldal. The network helps show where Dag Heldal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dag Heldal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 13 | |
| 2 | 2017 | 3 | |
| 3 | 2014 | 3 | |
| 4 | 2014 | 4 | |
| 5 | 2014 | 29 | |
| 6 | 2012 | 6 | |
| 7 | Allogen stamcelletransplantasjon hos voksne med akutt lymfoblastisk leukemi | 2008 | 1 |
| 8 | Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. | 2005 | 85 |
| 9 | 2004 | 9 | |
| 10 | 2003 | 16 | |
| 11 | [Hairy cell leukemia treated with cladribine]. | 2002 | 1 |
| 12 | 2002 | 26 | |
| 13 | 2000 | 100 | |
| 14 | 1997 | 28 | |
| 15 | 1995 | 10 | |
| 16 | 1995 | 15 | |
| 17 | 1995 | 67 |
About Dag Heldal
Dag Heldal is a scholar working on Hematology, Transplantation and Genetics, having authored 17 papers that have together received 416 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Chronic Lymphocytic Leukemia Research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Platelet Disorders and Treatments (3 papers), T-cell and B-cell Immunology (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (287 citations), Genetics (161 citations) and Transplantation (23 citations). Dag Heldal has collaborated with scholars based in Norway, Sweden and Canada. Frequent co-authors include Geir E. Tjønnfjord, S A Evensen, T Egeland, Lorentz Brinch, R Steen, D Albrechtsen, Torstein Egeland, Stig Sømme, Dag Kvale and Gunnar Juliusson. Their work appears in journals such as Bone Marrow Transplantation, British Journal of Haematology, Journal of Clinical Oncology, Cancer Immunology Immunotherapy and Journal of Clinical Apheresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.